Therapeutic Potential of HLA-I Polyreactive mAbs Mimicking the HLA-I Polyreactivity and Immunoregulatory Functions of IVIg.

Vaccines (Basel) · 2021 · PMC8235337 · PMID 34205517

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

However, the suppression of the secretion of the primary alloantibody by the mAb TFL-007s was highly significant compared to the IVIg-induced suppression.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.